Posted by Michael Wonder on 06 Dec 2018
Alberta boy with thyroid cancer runs, plays after taking U.S. approved drug
5 December 2018 - Health Canada is considering approving the oral treatment, larotrectinib.
This winter, Kayley Leeds can watch her nine-year-old ski and run around with his siblings, but a year and a half ago, her little boy was more likely to be in bed.
Ashton Leeds was only four when his mom found a lump in his neck. Shortly after, he was diagnosed with Stage 4 thyroid cancer.
